Bank of America Corp DE Cuts Stake in Phibro Animal Health Co. (NASDAQ:PAHC)

Bank of America Corp DE reduced its holdings in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 34.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 20,513 shares of the company’s stock after selling 10,847 shares during the period. Bank of America Corp DE owned about 0.05% of Phibro Animal Health worth $431,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the business. Ameriprise Financial Inc. grew its holdings in shares of Phibro Animal Health by 31.2% during the 4th quarter. Ameriprise Financial Inc. now owns 90,782 shares of the company’s stock valued at $1,906,000 after purchasing an additional 21,576 shares during the last quarter. Algert Global LLC boosted its position in Phibro Animal Health by 35.0% during the fourth quarter. Algert Global LLC now owns 96,272 shares of the company’s stock valued at $2,022,000 after buying an additional 24,937 shares during the period. Parvin Asset Management LLC purchased a new stake in Phibro Animal Health during the fourth quarter valued at about $282,000. AQR Capital Management LLC grew its stake in shares of Phibro Animal Health by 27.8% during the fourth quarter. AQR Capital Management LLC now owns 327,418 shares of the company’s stock valued at $6,876,000 after buying an additional 71,150 shares during the last quarter. Finally, Northern Trust Corp increased its holdings in shares of Phibro Animal Health by 7.2% in the fourth quarter. Northern Trust Corp now owns 245,110 shares of the company’s stock worth $5,147,000 after buying an additional 16,421 shares during the period. 99.34% of the stock is owned by hedge funds and other institutional investors.

Phibro Animal Health Stock Up 0.2%

NASDAQ PAHC opened at $24.39 on Thursday. Phibro Animal Health Co. has a 1 year low of $16.16 and a 1 year high of $26.55. The stock has a market capitalization of $988.62 million, a PE ratio of 50.81, a PEG ratio of 0.45 and a beta of 0.74. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The business’s 50-day moving average is $20.91 and its 200 day moving average is $21.88.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.11. The firm had revenue of $347.80 million for the quarter, compared to analyst estimates of $352.41 million. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Sell-side analysts forecast that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.97%. The ex-dividend date of this dividend is Wednesday, June 4th. Phibro Animal Health’s payout ratio is 61.54%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on PAHC shares. Wall Street Zen upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Friday, May 9th. Morgan Stanley increased their price objective on Phibro Animal Health from $20.00 to $21.00 and gave the company an “equal weight” rating in a research note on Thursday, May 8th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $20.00.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.